Ristaben
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ristaben, covering 2025-10-30 to 2025-10-30. Get the full timeline:
Most recent: EMA Authorised: Ristaben (sitagliptin) — Merck Sharp & Dohme B.V.
1 regulatory and trial event tracked for Ristaben, covering 2025-10-30 to 2025-10-30. Get the full timeline:
Most recent: EMA Authorised: Ristaben (sitagliptin) — Merck Sharp & Dohme B.V.